Home Cart Sign in  
Chemical Structure| 123447-62-1 Chemical Structure| 123447-62-1

Structure of Prulifloxacin
CAS No.: 123447-62-1

Chemical Structure| 123447-62-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Prulifloxacin is the prodrug of ulifloxacin, which is a broad-spectrum oral fluoroquinolone antibacterial agent.

Synonyms: NM441; AF 3013

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Prulifloxacin

CAS No. :123447-62-1
Formula : C21H20FN3O6S
M.W : 461.46
SMILES Code : O=C(C1=C(SC2C)N2C3=C(C=C(F)C(N4CCN(CC5=C(C)OC(O5)=O)CC4)=C3)C1=O)O
Synonyms :
NM441; AF 3013
MDL No. :MFCD00864847
InChI Key :PWNMXPDKBYZCOO-UHFFFAOYSA-N
Pubchem ID :65947

Safety of Prulifloxacin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00392574 Acute Gastroenteritis in Adult... More >> Travelers Less << Phase 3 Completed - United States, Pennsylvania ... More >> INC Research New Hope, Pennsylvania, United States, 18938 Less <<
NCT00448422 Acute Bacterial Gastroenteriti... More >>s Less << Phase 3 Completed - India ... More >> Goa Medical College Bambolim, Goa, India Less <<
NCT02130713 Chronic Bacterial Prostatitis Phase 4 Completed - Italy ... More >> policlinico Umberto I - Department of Gynecological-Obstetrics Sciences and Urological Sciences Roma, Italy, 00161 Less <<
NCT02157571 Acute Exacerbations of Chronic... More >> Bronchitis Less << Phase 3 Unknown September 2014 China ... More >> Nei Mongo medical University Recruiting Nei Mongo, China Contact: Liying Cui, Doctor    +86-471-6637524       Principal Investigator: Liying Cui, Doctor Less <<
NCT01231737 Urinary Tract Infection Phase 2 Unknown February 2012 -
NCT02439632 Acute Lower Urinary Tract Infe... More >>ction Less << Phase 3 Completed - China ... More >> Peking Medical Union Hospital Beijing, China, 100000 Less <<
NCT03201796 Chronic Bacterial Prostatitis Phase 2 Recruiting June 2020 Greece ... More >> Urology Clinic General Hospital of Athens "GENNIMATAS" Recruiting Athens, Greece, 15669 Contact: Ioannis Gkialas, MD    (+) 30 2107768328    giangkialas@yahoo.gr    Principal Investigator: Ioannis Gkialas, MD          Urology Department General Hospital of Piraeus "TZANEIO" Recruiting Piraeus, Greece, 18536 Contact: Konstantinos Stamatiou, MD    (+) 30 6934917578    stamatiouk@gmail.com    Principal Investigator: Konstantinos Stamatiou, MD          Italy U.O. di Urologia- Azienda Ospedaliera San Giuseppe Moscati Recruiting Avellino, Italy, 83100 Contact: Virgilio Cicalese, MD    0825 203384    vicicalese@aosgmoscati.av.it    Principal Investigator: Virgilio Cicalese, MD          U.O. Dipartimento della Donna, del bambino e delle malattie urologiche - Azienda ospedaliero- Universitaria e Policlinico di Bologna Recruiting Bologna, Italy, 40138 Contact: Eugenio Brunocilla, MD    +39 015 2142374    eugenio.brunocilla@unibo.it    Principal Investigator: Eugenio Brunocilla, MD          Urologia- Azienda Ospedaliero - Universitaria "Policlinico - Vittorio Emanuele" Recruiting Catania, Italy, 95123 Contact: Giuseppe Morgia, MD    095 378 2373    gmorgia@policlinico.unict.it    Principal Investigator: Giuseppe Morgia, MD          Clinica Urologica- Azienda Ospedaliero Universitaria Mater Domini Recruiting Catanzaro, Italy Contact: Rocco Damiano, MD    0961 364.7219    damiano@unicz.it    Principal Investigator: Rocco Damiano, MD          Azienda Ospedaliero-Universitaria "Careggi" Recruiting Firenze, Italy, 50134 Contact: Marco Carini, MD    055 2758011    marco.carini@unifi.it    Principal Investigator: Marco Carini, MD          Azienda Ospedaliera Universitaria "Federico II"- Dip. Di Ostreticia, ginecologia, Urologia Recruiting Napoli, Italy, 80131 Contact: Vincenzo Mirone, MD    +39 081 746 2611    mirone@unina.it    Principal Investigator: Vincenzo Mirone, MD          Clinica Urologica del Dipartimento di Scienze Chirurgiche- Policlinico Universitario Agostino Gemelli di Roma Recruiting Roma, Italy, 00168 Contact: Emilio Sacco, MD    0630155290    emilio.sacco@policlinicogemelli.it    Principal Investigator: Emilio Sacco, MD          S.C. Urologia- AO "Città della Salute e della Scienza" di Torino - OSP.S. GIOV.BATTISTA MOLINETTE Recruiting Torino, Italy, 10126 Contact: Paolo Gontero, MD    0116706518    paolo.gontero@unito.it    Principal Investigator: Paolo Gontero          Urologia- Ospedale di Trento- Presidio ospedaliero S. Chiara - Azienda Provinciale per i servizi sanitari (APSS) Recruiting Trento, Italy, 38123 Contact: Tommaso CAI, MD       tommaso.cai@apss.tn.it    Principal Investigator: Tommaso Cai, MD Less <<
NCT01710488 COPD Exacerbation Phase 4 Completed - Italy ... More >> Hospita "San Francesco Caracciolo" Agnone, Italy, 86081 Hospital of Alghero Alghero, Italy, 07041 Hospital "Cardinal Massaia" Asti, Italy, 14100 Hospital "Fatebenefratelli" Benevento, Italy, 82100 Hospital of Bordighera Bordighera, Italy, 18012 Hospital "San Giovanni di Dio" Cagliari, Italy, 09124 Hospital "Pugliese-Ciaccio" Catanzaro, Italy, 88100 Hospital "L.Parodi Delfino" Colleferro, Italy, 00034 Hospita "San Giovanni di Dio" Crotone, Italy, 88900 Hospital "E.Profili" of Fabriano Fabriano, Italy, 60044 Hospital "F. Veneziale" Isernia, Italy, 86170 Hospital Civile Legnano Legnano, Italy, 20025 Hospital of Ortona Ortona, Italy, 66100 Hospital Fatebenefratelli "Buccheri La Ferla" Palermo, Italy, 90123 Hospital "Sant'Anna" Reggio Emilia, Italy, 42035 Hospital " Santa Maria Nuova" Reggio Emilia, Italy, 42123 Hospital "Policlinico Universitario Campus Biomedico" Rome, Italy, 00128 Hospital "Casa Sollievo della Sofferenza" San Giovanni Rotondo, Italy, 71013 Hospital of Scandiano Scandiano, Italy, 42019 Hospital "Paolo Dettori" Tempio Pausania, Italy, 0729 Hospital "Santa Maria" of Terni Terni, Italy, 05100 Hospital "San Giovanni Bosco" Torino, Italy, 10100 Hospital "Jazzolino" Vibo Valentia, Italy, 89900 Hospital "San Bortolo" Vicenza, Italy, 36100 Hospital "Santa Maria Maddalena" Volterra, Italy, 56048 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.17mL

0.43mL

0.22mL

10.84mL

2.17mL

1.08mL

21.67mL

4.33mL

2.17mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories